Piper Sandler keeps Neutral rating on Viatris; $13 target
Piper Sandler maintained a Neutral rating on Viatris and set a $13.00 price target, implying 21.9% downside versus the Sep 15 close of $16.65.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.